Company Alliance Pharma plc

Equities

APH

GB0031030819

Pharmaceuticals

Market Closed - London S.E. 16:35:02 17/07/2024 BST 5-day change 1st Jan Change
35.5 GBX -0.56% Intraday chart for Alliance Pharma plc -0.70% -12.35%

Business Summary

Alliance Pharma plc is a United Kingdom-based international consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. Its segments include Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include the Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Aloclair Plus Spray, Aloclair Plus Mouthwash, Anbesol Adult Strength Gel, Anbesol Teething Gel, Anbesol Liquid, Atopiclair Cream, and Atopiclair Lotion. It holds marketing rights to around 80 consumer healthcare brands and prescription medicines, which are sold worldwide in more than 100 countries.

Number of employees: 292

Sales per Business

GBP in Million2022Weight2023Weight Delta
Consumer Healthcare
74.3 %
121 72.0 % 134 74.3 % +11.37%
Prescription Medicines
25.7 %
47 28.0 % 46 25.7 % -0.95%

Sales per region

GBP in Million2022Weight2023Weight Delta
Europe, Middle East and Africa
43.8 %
79 47.1 % 79 43.8 % +0.35%
Asia Pacific and China
40.1 %
59 35.4 % 72 40.1 % +22.36%
Americas
16.1 %
29 17.5 % 29 16.1 % -0.86%

Managers

Managers TitleAgeSince
Director of Finance/CFO 58 27/09/15
Chief Operating Officer - 31/01/23
Chief Operating Officer 56 31/12/12
General Counsel - 31/12/16
Corporate Officer/Principal - 31/12/13
Human Resources Officer - 31/12/10

Members of the board

Members of the board TitleAgeSince
Director/Board Member 55 31/01/23
Director/Board Member 58 31/12/18
Director/Board Member 57 11-06
Chairman 53 02-18
Director of Finance/CFO 58 27/09/15
Chief Operating Officer - 31/01/23
Director/Board Member 46 30/11/21
Director/Board Member 52 11-06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 540,565,539 474,600,039 ( 87.80 %) 0 87.80 %

Shareholders

NameEquities%Valuation
DBAY Advisors Ltd.
26.22 %
141,696,240 26.22 % 70 M p
Slater Investments Ltd.
9.308 %
50,300,424 9.308 % 25 M p
Rathbones Investment Management Ltd.
4.805 %
25,968,567 4.805 % 13 M p
Fidelity Management & Research Co. LLC
3.635 %
19,644,025 3.635 % 10 M p
Artemis Investment Management LLP
3.211 %
17,354,565 3.211 % 9 M p
16,200,462 2.998 % 8 M p
Van Lanschot Kempen Investment Management NV
2.779 %
15,019,017 2.779 % 7 M p
RBC Global Asset Management (UK) Ltd.
2.692 %
14,546,460 2.692 % 7 M p
Rowan Dartington & Co. Ltd. (Broker)
2.671 %
14,435,000 2.671 % 7 M p
Brooks Macdonald Asset Management Ltd.
2.208 %
11,934,000 2.208 % 6 M p

Company contact information

Alliance Pharma Plc

Avonbridge House Bath Road

SN15 2BB, Chippenham

+44 12 4946 6966

http://www.alliancepharma.co.uk
address Alliance Pharma plc(APH)

Group companies

NameCategory and Sector
Pharmaceuticals: Major

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.355 GBP
Average target price
0.6243 GBP
Spread / Average Target
+75.86%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. APH Stock
  4. Company Alliance Pharma plc